Cargando…
Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns
BACKGROUND: The frequency of preterm labour has risen over the last few years. Hence, there is growing interest in the identification of markers that may facilitate prediction and prevention of premature birth complications. Here, we studied the association of the number of circulating stem cell pop...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573966/ https://www.ncbi.nlm.nih.gov/pubmed/22985188 http://dx.doi.org/10.1186/1471-2431-12-148 |
_version_ | 1782259536477814784 |
---|---|
author | Kotowski, Maciej Safranow, Krzysztof Kawa, Miłosz P Lewandowska, Joanna Kłos, Patrycja Dziedziejko, Violetta Paczkowska, Edyta Czajka, Ryszard Celewicz, Zbigniew Rudnicki, Jacek Machaliński, Bogusław |
author_facet | Kotowski, Maciej Safranow, Krzysztof Kawa, Miłosz P Lewandowska, Joanna Kłos, Patrycja Dziedziejko, Violetta Paczkowska, Edyta Czajka, Ryszard Celewicz, Zbigniew Rudnicki, Jacek Machaliński, Bogusław |
author_sort | Kotowski, Maciej |
collection | PubMed |
description | BACKGROUND: The frequency of preterm labour has risen over the last few years. Hence, there is growing interest in the identification of markers that may facilitate prediction and prevention of premature birth complications. Here, we studied the association of the number of circulating stem cell populations with the incidence of complications typical of prematurity. METHODS: The study groups consisted of 90 preterm (23–36 weeks of gestational age) and 52 full-term (37–41 weeks) infants. Non-hematopoietic stem cells (non-HSCs; CD45(-)lin(-)CD184(+)), enriched in very small embryonic-like stem cells (VSELs), expressing pluripotent (Oct-4, Nanog), early neural (β-III-tubulin), and oligodendrocyte lineage (Olig-1) genes as well as hematopoietic stem cells (HSCs; CD45(+)lin(-)CD184(+)), and circulating stem/progenitor cells (CSPCs; CD133(+)CD34(+); CD133(-)CD34(+)) in association with characteristics of prematurity and preterm morbidity were analyzed in cord blood (CB) and peripheral blood (PB) until the sixth week after delivery. Phenotype analysis was performed using flow cytometry methods. Clonogenic assays suitable for detection of human hematopoietic progenitor cells were also applied. The quantitative parameters were compared between groups by the Mann–Whitney test and between time points by the Friedman test. Fisher’s exact test was used for qualitative variables. RESULTS: We found that the number of CB non-HSCs/VSELs is inversely associated with the birth weight of preterm infants. More notably, a high number of CB HSCs is strongly associated with a lower risk of prematurity complications including intraventricular hemorrhage, respiratory distress syndrome, infections, and anemia. The number of HSCs remains stable for the first six weeks of postnatal life. Besides, the number of CSPCs in CB is significantly higher in preterm infants than in full-term neonates (p < 0.0001) and extensively decreases in preterm babies during next six weeks after birth. Finally, the growth of burst-forming unit of erythrocytes (BFU-E) and colony-forming units of granulocyte-macrophage (CFU-GM) obtained from CB of premature neonates is higher than those obtained from CB of full-term infants and strongly correlates with the number of CB-derived CSPCs. CONCLUSION: We conclude that CB HSCs are markedly associated with the development of premature birth complications. Thus, HSCs ought to be considered as the potential target for further research as they may be relevant for predicting and controlling the morbidity of premature infants. Moreover, the observed levels of non-HSCs/VSELs circulating in CB are inversely associated with the birth weight of preterm infants, suggesting non-HSCs/VSELs might be involved in the maturation of fetal organism. |
format | Online Article Text |
id | pubmed-3573966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35739662013-02-16 Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns Kotowski, Maciej Safranow, Krzysztof Kawa, Miłosz P Lewandowska, Joanna Kłos, Patrycja Dziedziejko, Violetta Paczkowska, Edyta Czajka, Ryszard Celewicz, Zbigniew Rudnicki, Jacek Machaliński, Bogusław BMC Pediatr Research Article BACKGROUND: The frequency of preterm labour has risen over the last few years. Hence, there is growing interest in the identification of markers that may facilitate prediction and prevention of premature birth complications. Here, we studied the association of the number of circulating stem cell populations with the incidence of complications typical of prematurity. METHODS: The study groups consisted of 90 preterm (23–36 weeks of gestational age) and 52 full-term (37–41 weeks) infants. Non-hematopoietic stem cells (non-HSCs; CD45(-)lin(-)CD184(+)), enriched in very small embryonic-like stem cells (VSELs), expressing pluripotent (Oct-4, Nanog), early neural (β-III-tubulin), and oligodendrocyte lineage (Olig-1) genes as well as hematopoietic stem cells (HSCs; CD45(+)lin(-)CD184(+)), and circulating stem/progenitor cells (CSPCs; CD133(+)CD34(+); CD133(-)CD34(+)) in association with characteristics of prematurity and preterm morbidity were analyzed in cord blood (CB) and peripheral blood (PB) until the sixth week after delivery. Phenotype analysis was performed using flow cytometry methods. Clonogenic assays suitable for detection of human hematopoietic progenitor cells were also applied. The quantitative parameters were compared between groups by the Mann–Whitney test and between time points by the Friedman test. Fisher’s exact test was used for qualitative variables. RESULTS: We found that the number of CB non-HSCs/VSELs is inversely associated with the birth weight of preterm infants. More notably, a high number of CB HSCs is strongly associated with a lower risk of prematurity complications including intraventricular hemorrhage, respiratory distress syndrome, infections, and anemia. The number of HSCs remains stable for the first six weeks of postnatal life. Besides, the number of CSPCs in CB is significantly higher in preterm infants than in full-term neonates (p < 0.0001) and extensively decreases in preterm babies during next six weeks after birth. Finally, the growth of burst-forming unit of erythrocytes (BFU-E) and colony-forming units of granulocyte-macrophage (CFU-GM) obtained from CB of premature neonates is higher than those obtained from CB of full-term infants and strongly correlates with the number of CB-derived CSPCs. CONCLUSION: We conclude that CB HSCs are markedly associated with the development of premature birth complications. Thus, HSCs ought to be considered as the potential target for further research as they may be relevant for predicting and controlling the morbidity of premature infants. Moreover, the observed levels of non-HSCs/VSELs circulating in CB are inversely associated with the birth weight of preterm infants, suggesting non-HSCs/VSELs might be involved in the maturation of fetal organism. BioMed Central 2012-09-17 /pmc/articles/PMC3573966/ /pubmed/22985188 http://dx.doi.org/10.1186/1471-2431-12-148 Text en Copyright ©2012 Kotowski et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kotowski, Maciej Safranow, Krzysztof Kawa, Miłosz P Lewandowska, Joanna Kłos, Patrycja Dziedziejko, Violetta Paczkowska, Edyta Czajka, Ryszard Celewicz, Zbigniew Rudnicki, Jacek Machaliński, Bogusław Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
title | Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
title_full | Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
title_fullStr | Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
title_full_unstemmed | Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
title_short | Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
title_sort | circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573966/ https://www.ncbi.nlm.nih.gov/pubmed/22985188 http://dx.doi.org/10.1186/1471-2431-12-148 |
work_keys_str_mv | AT kotowskimaciej circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT safranowkrzysztof circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT kawamiłoszp circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT lewandowskajoanna circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT kłospatrycja circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT dziedziejkovioletta circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT paczkowskaedyta circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT czajkaryszard circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT celewiczzbigniew circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT rudnickijacek circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns AT machalinskibogusław circulatinghematopoieticstemcellcountisavaluablepredictorofprematuritycomplicationsinpretermnewborns |